In this digital age, developing patient-centric support and adherence programs are crucial for pharmaceutical companies to stay ahead of the competition. It is worth noting that, effective adherence programs help take full advantage of prescription revenue, for both new and refill prescriptions.
Healthcare industry is transforming rapidly as new models of care and reimbursement emerge. P4 Medicine is one of them. P4 Medicine stands for predictive, preventive, personalized, and participatory.
With the boom of targeted therapies, P4 medicine model is expected to gain momentum as time progresses. As companies continue to develop more customized treatments, their patient engagement programs must reflect that personalized approach.
Today’s most popular patient engagement programs go beyond just the ‘patient’. These programs are focused on supporting the well-being of the whole person.
Customized patient care based on patient profile
P4 medicine programs which support targeted treatments are specifically personalized to particular patient profiles. Most pharmaceutical companies have data on patient demographics and details on expected side effects. This data is usually acquired during initial research trial phases of specialty drugs, and should be applied to the development of P4 medicine programs.
For instance, certain cancer treatments may be the second or third line of a staged treatment program which provides insight regarding how this treatment fits the patient’s entire healthcare journey. Since the possible side effects are already known, specifically those that change during the course of a treatment can help guide healthcare employees in their interactions with the patients in a day-to-day basis.
Flexible and adaptive treatment
Being adaptive to the patient’s needs differentiate your P4 medicine program. This is true by all sense in programs that accompany specialty treatments, medical practitioners need to have some flexibility in their conversations with patients, which means not only following a line-by-line script or the recommended program sequence. It also needs healthcare employees to identify the specific needs of the patient and complicating factors that lead to more complex therapies.
With P4 medicine in place, patient adherence rates are more likely to soar and patients would be satisfied with the adherence program and have a more positive view of the treatment. Taking this approach, insurance companies can multiply their profits.
P4 medicine is the beginning of a new era of medicine where patients will be active participants; where medical practitioners are empowered with more data to make health decisions that will positively transform the course of patient’s lives.